RCS - OptiBiotix Health - Investor Teach In <Origin Href="QuoteRef">OPTIO.L</Origin>

OptiBiotix HealthAnnouncement

23/02/2015 07:01

RNS Number : 5206F
OptiBiotix Health PLC
23 February 2015
Optibiotix Health Plc
(the "Company" or the "Group")
Investor Teach-In
OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes announces it will be holding a teach-in for investors and analysts on Wednesday, 18th March 2015. 
The event will be held in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad Street, London EC2N 1DX from 4.30pm.
A presentation will be given founder & CEO of OptiBiotix, Stephen O'Hara, for approximately one hour. The presentation will include an overview of the Company and an outline of their strategy to deliver value for shareholders. This will be followed by light refreshments and an opportunity to network. 
To register for the event, please email optibiotix@walbrookpr.com or call the Walbrook PR team below. 
OptiBiotix Health plc
www.optibiotix.com
Stephen O'Hara, Chief Executive
Contact via Walbrook below
Cairn Financial Advisers LLP
Tel: 020 7148 7900
Liam Murray / Avi Robinson
Hybridan LLP (Joint Broker)
Claire Louise Noyce
Tel: 020 3713 4581
Peterhouse Corporate Finance Ltd (Joint Broker)
Tel: 020 7469 0936
Lucy Williams / Duncan Vasey
Walbrook PR Ltd
Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy
Mob: 07876 741 001
Mike Wort
Mob: 07900 608 002

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NRALLFVRFLIIFIE